Management and Board of Directors
Christian Espeseth
CEO
Christian has a solid background in the nutraceutical industry as well as the communications sector. With experience spanning various startups and larger growth companies, he can demonstrate success not only in his own ventures but also in projects for a wide range of industries, including FMCG, organizations, health, and nutraceuticals.
He has extensive leadership experience at various levels within the communications industry, most recently as the CEO of dentsu X and the Growth Director for dentsu Norway. He possesses invaluable expertise in business development and growth, consistently delivering results. Throughout his professional career, he has maintained a focus on building teams that foster both unity and expansion. He excels in business strategy, concept/product development, organizational development, and, notably, culture and operationalization. He is known for his infectious enthusiasm and his ability to identify opportunities in almost any situation.
Since 2018, he has served as the chairman of Eqology, which is owned by ImmunoPharma. During this period, the company has experienced significant growth.
Christian holds a Master’s degree in Business and Marketing from BI (Norwegian Business School)
Kjetil Ramsøy
Chairman of the Board
Kjetil Ramsøy has an extensive background in senior leadership positions in Scandinavia and the US for over 20 years. He has experience as CFO in industries spanning from power supplies and electronics to the oil service and health & lifestyle industry. He has been working in both small and large global organizations. Before he joined the ImmunoPharma Group in October 2021, he served as CFO and later CEO for NattoPharma ASA, a publicly listed company on the Norwegian stock exchange, operating in the health and life sciences industry, being the world leader in producing and distributing vitamin K2.
Kim Øien
Board member
Kim Øien founded the Norwegian direct sales company TG Montgomery in 2006. He built the company from zero to sixty thousand customers and 100 million NOK turnover through organic growth (no investor money). He is the initiator and architect behind the ground-breaking new business intelligence and marketing automation system developed and owned by TG Montgomery.
Frode Bohan
Founder and board member
Frode Bohan is one of the founders of ImmunoPharma. He has a two-decade-long track-record of founding and establishing successful companies in the pharmaceutical and nutraceutical sector.
He founded NattoPharma ASA in 2004. After a period of absence from the company, he rejoined NattoPharma in 2012 and directed a successful turnover setting the company firmly on a path towards success.
Mr. Bohan's interest in AndoSan goes back to the start in 2002. He founded a small company to make AndoSan available as a niche product. In December 2009, he co-founded ImmunoPharma to develop a broader market for the product. He has since worked to develop ImmunoPharma into a major innovative health solutions provider and has also been involved in several other successful health product-related projects.